Emerging therapeutics for primary peritoneal cancer

Author： Slomovitz Brian M Worley Michael J Markman Maurie Coleman Robert L

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.1, 2011-03, pp. : 71-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Superoxide dismutase: an emerging target for cancer therapeutics

By Hileman Elizabeth A Achanta Geetha Huang Peng

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 6, 2001-12 ,pp. : 697-710

Informa Healthcare

Access to resources Recommend Favorite

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

By Tandon Manish Vemula Sai Vikram Mittal Suresh K

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 31-51

Informa Healthcare

Access to resources Recommend Favorite

Emerging Developments in RNA Therapeutics

By Read Martin L Farrow Paul J Seymour Leonard W

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 299-303

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: Emerging Importance for Cancer Treatment and Therapy of Chronic Disease)

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 77-77

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Peptide Therapeutics for Inflammatory Diseases

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 4, 2006-08 ,pp. : 241-246

Bentham Science Publishers

Access to resources Recommend Favorite